Worldwide Clinical Trials acquires Catalyst Clinical Research

Worldwide Clinical Trials agreed to acquire Catalyst Clinical Research. Reported deal value: Undisclosed. Status: Pending. Sector: Contract Research Organization (CRO). Target headquarters context: Wilmington, North Carolina, United States.

This page summarizes publicly available information about the transaction as of 2026-01-20. Figures and status may change as filings and press coverage update.

| Press Releases Worldwide Clinical Trials Enters Definitive Agreement to Acquire Catalyst Clinical Research Combination to add key functional service provider capabilities, deliver immediate uplift in oncology , strengthen global site reach, and accelerate technology integration – enhancing speed, transparency, and value for customers RESEARCH TRIANGLE PARK , N.C. and NOTTINGHAM, U.K